• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Atamyo Therapeutics Presents Promising Results for ATA-200

    BUSSINESSWIRE

    Atamyo Obtains RA in Europe for Trial to Treat Limb-Girdle MD Type 2C/R5

    BUSINESSWIRE

    Atamyo Therapeutics Announces participation in Conferences

    BUSINESSWIRE

    Atamyo doses first subject in Phase I/II muscular dystrophy therapy trial

    CLINICALTRIALSARENA

    Atamyo Therapeutics Announces First Patient Dosed with ATA-100

    BUSINESSWIRE

    Atamyo Announces Significant Milestones for ATA-100 and ATA-200

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.